Literature DB >> 3046669

Renal function and fluid therapy in high risk infants.

W Oh1.   

Abstract

In recent years, the survival rate of high risk infants has markedly increased. The role of such medical management as fluid, electrolyte and nutritional therapy have assumed a greater importance in assuring optimal quality of the survivors. The very low birth weight infants, particularly those with respiratory distress syndrome and perinatal asphyxia, are at highest risk. The inefficient renal function, unique characteristic of body fluid composition and/or presence of severe clinical illness often make the management of fluid and electrolytes in this group of infants difficult. The numerous factors that influence insensible water loss make calculation of fluid management in the high risk infant even more challenging. Systematic collection of data such as daily body weight, intake, output, urine specific gravity and serum electrolyte is essential to appropriately maintain fluid and electrolytes balance in these infants. Respiratory distress syndrome is a common problem in premature infants and the fluid and electrolyte management in these infants will require similar attention to details as described for the fluid and electrolytes of very low birth infants. Perinatal asphyxia often results in oliguria or anuria because of possible development of inappropriate ADH secretion or acute tubular necrosis. It is essential that fluid restriction be done on the first day or two of life to avoid fluid overload.

Entities:  

Mesh:

Year:  1988        PMID: 3046669     DOI: 10.1159/000242795

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  3 in total

1.  Risk factors and correlates of neonatal growth velocity in extremely low gestational age newborns: the ELGAN Study.

Authors:  Julie Bartholomew; Camilia R Martin; Elizabeth Allred; Minghua L Chen; Richard A Ehrenkranz; Olaf Dammann; Alan Leviton
Journal:  Neonatology       Date:  2013-10-30       Impact factor: 4.035

Review 2.  Neonatal resuscitation in low-resource settings: what, who, and how to overcome challenges to scale up?

Authors:  Stephen N Wall; Anne C C Lee; Susan Niermeyer; Mike English; William J Keenan; Wally Carlo; Zulfiqar A Bhutta; Abhay Bang; Indira Narayanan; Iwan Ariawan; Joy E Lawn
Journal:  Int J Gynaecol Obstet       Date:  2009-10       Impact factor: 3.561

Review 3.  Arginine Vasopressin and Copeptin in Perinatology.

Authors:  Katrina Suzanne Evers; Sven Wellmann
Journal:  Front Pediatr       Date:  2016-08-02       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.